US Stock MarketDetailed Quotes

TherapeuticsMD (TXMD)

Watchlist
  • 2.220
  • -0.020-0.89%
Trading Jan 16 11:06 ET
25.70MMarket Cap88.80P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TherapeuticsMD (TXMD) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
43.33%784K
306.84%952K
25.56%393K
35.25%1.76M
32.87%667K
1,132.08%547K
-46.45%234K
-24.76%313K
-98.14%1.3M
-99.27%502K
Operating revenue
43.33%784K
306.84%952K
25.56%393K
35.25%1.76M
32.87%667K
1,132.08%547K
-46.45%234K
-24.76%313K
-98.14%1.3M
-99.27%502K
Cost of revenue
Gross profit
1,132.08%547K
-46.45%234K
Operating expense
-3.99%1.61M
-6.53%1.65M
-19.18%1.18M
-46.53%5.25M
-101.89%-40K
-2.27%1.68M
-39.43%1.76M
-52.81%1.46M
-83.03%9.83M
-80.16%2.11M
Selling and administrative expenses
-4.23%1.52M
-1.96%1.55M
-18.23%1.08M
-46.71%4.74M
-109.49%-140K
-0.31%1.59M
-43.11%1.58M
-56.74%1.32M
-84.30%8.9M
-85.73%1.48M
-General and administrative expense
-4.23%1.52M
----
----
----
----
--1.59M
----
----
----
----
Depreciation amortization depletion
0.00%96K
-46.67%96K
-28.57%95K
-44.79%509K
-84.30%100K
-26.15%96K
40.63%180K
392.59%133K
-22.72%922K
106.15%637K
-Depreciation and amortization
0.00%96K
-46.67%96K
-28.57%95K
-44.79%509K
-84.30%100K
-26.15%96K
40.63%180K
392.59%133K
-22.72%922K
106.15%637K
Operating profit
26.81%-830K
54.52%-695K
31.44%-783K
59.03%-3.49M
143.89%707K
36.04%-1.13M
38.19%-1.53M
57.18%-1.14M
-179.93%-8.52M
-102.78%-1.61M
Net non-operating interest income expense
0.00%-3K
60.00%-2K
-2K
85.00%-3K
88.89%-5K
0
Non-operating interest expense
0.00%3K
-60.00%2K
--2K
----
----
-85.00%3K
-88.89%5K
--0
----
----
Other net income (expense)
54.91%883K
157.14%1.24M
-64.86%117K
47.12%1.15M
-618.18%-632K
58.77%570K
368.93%483K
-18.18%333K
108.14%781K
99.07%-88K
Special income (charges)
---32K
--0
---88K
---1.27M
---7K
--0
---1.26M
--0
--0
--0
-Less:Impairment of capital assets
--32K
--0
--88K
--1.27M
--7K
--0
--1.26M
--0
--0
--0
-Write off
----
--0
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
60.53%915K
-28.78%1.24M
-38.44%205K
209.48%2.42M
-610.23%-625K
58.77%570K
1,593.20%1.74M
-18.18%333K
767.52%781K
-900.00%-88K
Income before tax
108.82%50K
151.90%545K
17.43%-668K
69.74%-2.34M
105.24%83K
60.46%-567K
56.50%-1.05M
64.98%-809K
-820.86%-7.74M
-103.27%-1.58M
Income tax
0
0
-32K
27.91%-31K
27.91%-31K
0
0
0
-43K
-43K
Net income
124.96%152K
150.55%551K
11.04%-653K
78.78%-2.18M
128.54%252K
81.97%-609K
54.85%-1.09M
79.63%-734K
-109.18%-10.28M
-101.14%-883K
Net income continuous Operations
108.82%50K
151.90%545K
21.38%-636K
69.97%-2.31M
107.40%114K
60.46%-567K
56.50%-1.05M
64.98%-809K
-816.85%-7.7M
-103.18%-1.54M
Net income discontinuous operations
342.86%102K
115.00%6K
-122.67%-17K
105.08%131K
-79.03%138K
97.84%-42K
---40K
105.80%75K
-102.33%-2.58M
-97.75%658K
Minority interest income
Net income attributable to the parent company
124.96%152K
150.55%551K
11.04%-653K
78.78%-2.18M
128.54%252K
81.97%-609K
54.85%-1.09M
79.63%-734K
-109.18%-10.28M
-101.14%-883K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
124.96%152K
150.55%551K
11.04%-653K
78.78%-2.18M
128.54%252K
81.97%-609K
54.85%-1.09M
79.63%-734K
-109.18%-10.28M
-101.14%-883K
Basic earnings per share
120.00%0.01
155.56%0.05
0.00%-0.06
80.61%-0.19
133.33%0.02
84.38%-0.05
62.50%-0.09
83.78%-0.06
-107.90%-0.98
-100.70%-0.06
Diluted earnings per share
120.00%0.01
155.56%0.05
0.00%-0.06
80.61%-0.19
133.33%0.02
84.38%-0.05
62.50%-0.09
83.78%-0.06
-108.19%-0.98
-100.74%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 43.33%784K306.84%952K25.56%393K35.25%1.76M32.87%667K1,132.08%547K-46.45%234K-24.76%313K-98.14%1.3M-99.27%502K
Operating revenue 43.33%784K306.84%952K25.56%393K35.25%1.76M32.87%667K1,132.08%547K-46.45%234K-24.76%313K-98.14%1.3M-99.27%502K
Cost of revenue
Gross profit 1,132.08%547K-46.45%234K
Operating expense -3.99%1.61M-6.53%1.65M-19.18%1.18M-46.53%5.25M-101.89%-40K-2.27%1.68M-39.43%1.76M-52.81%1.46M-83.03%9.83M-80.16%2.11M
Selling and administrative expenses -4.23%1.52M-1.96%1.55M-18.23%1.08M-46.71%4.74M-109.49%-140K-0.31%1.59M-43.11%1.58M-56.74%1.32M-84.30%8.9M-85.73%1.48M
-General and administrative expense -4.23%1.52M------------------1.59M----------------
Depreciation amortization depletion 0.00%96K-46.67%96K-28.57%95K-44.79%509K-84.30%100K-26.15%96K40.63%180K392.59%133K-22.72%922K106.15%637K
-Depreciation and amortization 0.00%96K-46.67%96K-28.57%95K-44.79%509K-84.30%100K-26.15%96K40.63%180K392.59%133K-22.72%922K106.15%637K
Operating profit 26.81%-830K54.52%-695K31.44%-783K59.03%-3.49M143.89%707K36.04%-1.13M38.19%-1.53M57.18%-1.14M-179.93%-8.52M-102.78%-1.61M
Net non-operating interest income expense 0.00%-3K60.00%-2K-2K85.00%-3K88.89%-5K0
Non-operating interest expense 0.00%3K-60.00%2K--2K---------85.00%3K-88.89%5K--0--------
Other net income (expense) 54.91%883K157.14%1.24M-64.86%117K47.12%1.15M-618.18%-632K58.77%570K368.93%483K-18.18%333K108.14%781K99.07%-88K
Special income (charges) ---32K--0---88K---1.27M---7K--0---1.26M--0--0--0
-Less:Impairment of capital assets --32K--0--88K--1.27M--7K--0--1.26M--0--0--0
-Write off ------0------------------0------------
Other non- operating income (expenses) 60.53%915K-28.78%1.24M-38.44%205K209.48%2.42M-610.23%-625K58.77%570K1,593.20%1.74M-18.18%333K767.52%781K-900.00%-88K
Income before tax 108.82%50K151.90%545K17.43%-668K69.74%-2.34M105.24%83K60.46%-567K56.50%-1.05M64.98%-809K-820.86%-7.74M-103.27%-1.58M
Income tax 00-32K27.91%-31K27.91%-31K000-43K-43K
Net income 124.96%152K150.55%551K11.04%-653K78.78%-2.18M128.54%252K81.97%-609K54.85%-1.09M79.63%-734K-109.18%-10.28M-101.14%-883K
Net income continuous Operations 108.82%50K151.90%545K21.38%-636K69.97%-2.31M107.40%114K60.46%-567K56.50%-1.05M64.98%-809K-816.85%-7.7M-103.18%-1.54M
Net income discontinuous operations 342.86%102K115.00%6K-122.67%-17K105.08%131K-79.03%138K97.84%-42K---40K105.80%75K-102.33%-2.58M-97.75%658K
Minority interest income
Net income attributable to the parent company 124.96%152K150.55%551K11.04%-653K78.78%-2.18M128.54%252K81.97%-609K54.85%-1.09M79.63%-734K-109.18%-10.28M-101.14%-883K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 124.96%152K150.55%551K11.04%-653K78.78%-2.18M128.54%252K81.97%-609K54.85%-1.09M79.63%-734K-109.18%-10.28M-101.14%-883K
Basic earnings per share 120.00%0.01155.56%0.050.00%-0.0680.61%-0.19133.33%0.0284.38%-0.0562.50%-0.0983.78%-0.06-107.90%-0.98-100.70%-0.06
Diluted earnings per share 120.00%0.01155.56%0.050.00%-0.0680.61%-0.19133.33%0.0284.38%-0.0562.50%-0.0983.78%-0.06-108.19%-0.98-100.74%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +5.33%
Sample Name
Sample Code
 +2.00%
Sample Name
Sample Code
 +1.44%
4
Warner Bros Discovery
WBD
+0.88%
5
Tempus AI
TEM
+0.79%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.59%
Sample Name
Sample Code
 +10.40%
Sample Name
Sample Code
 +9.01%
4
Kingsoft Cloud
KC
+7.40%
5
Taiwan Semiconductor
TSM
+6.16%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -